[go: up one dir, main page]

MX2022016117A - Tabletas rapidamente orodispersables que tienen una cavidad interior. - Google Patents

Tabletas rapidamente orodispersables que tienen una cavidad interior.

Info

Publication number
MX2022016117A
MX2022016117A MX2022016117A MX2022016117A MX2022016117A MX 2022016117 A MX2022016117 A MX 2022016117A MX 2022016117 A MX2022016117 A MX 2022016117A MX 2022016117 A MX2022016117 A MX 2022016117A MX 2022016117 A MX2022016117 A MX 2022016117A
Authority
MX
Mexico
Prior art keywords
payloads
rapidly
tablets
payload
bound
Prior art date
Application number
MX2022016117A
Other languages
English (en)
Inventor
Thomas G West
Thomas J Bradbury
Jaedeok Yoo
Aleece M Phillips
Original Assignee
Aprecia Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aprecia Pharmaceuticals LLC filed Critical Aprecia Pharmaceuticals LLC
Publication of MX2022016117A publication Critical patent/MX2022016117A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporciona una forma de dosificación rápidamente orodispersable que comprende una matriz porosa de polvo unido y una o más cavidades internas, así como también métodos de impresión tridimensional para hacer la misma. Cada cavidad interna se configura para contener una o más cargas útiles, particularmente medicamentos farmacéuticos, mientras que aísla las cargas útiles del ambiente externo fuera de la forma de dosificación. Cada carga útil puede estar contenida dentro de su cavidad en su forma nativa sin tener que ser combinada con la matriz de polvo unido o el líquido aglutinante. Las formas de dosificación pueden desintegrarse en agua o saliva en menos de dos minutos, independientemente de la(s) carga(s) útil(es) o medicamento(s) contenidos en el interior. Las formas de dosificación se pueden formular como tabletas unitarias, o como tabletas de dos piezas que comprenden un cuerpo de recipiente y un cuerpo de tapa que se aseguran juntos para aislar una o más de las cavidades y sus cargas útiles en el interior.
MX2022016117A 2020-06-26 2021-06-25 Tabletas rapidamente orodispersables que tienen una cavidad interior. MX2022016117A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063044740P 2020-06-26 2020-06-26
US202163214343P 2021-06-24 2021-06-24
PCT/US2021/039137 WO2021263132A1 (en) 2020-06-26 2021-06-25 Rapidly-orodispersible tablets having an interior cavity

Publications (1)

Publication Number Publication Date
MX2022016117A true MX2022016117A (es) 2023-04-05

Family

ID=77022256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016117A MX2022016117A (es) 2020-06-26 2021-06-25 Tabletas rapidamente orodispersables que tienen una cavidad interior.

Country Status (8)

Country Link
US (2) US11433022B2 (es)
EP (1) EP4171518B1 (es)
JP (1) JP2023533478A (es)
CN (1) CN116018131A (es)
AU (1) AU2021296908A1 (es)
CA (1) CA3183295A1 (es)
MX (1) MX2022016117A (es)
WO (1) WO2021263132A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114569570B (zh) * 2022-03-15 2023-03-24 浙江长典药物技术开发有限公司 一种吗替麦考酚酯及制备方法
EP4482466B1 (de) * 2022-06-14 2025-11-05 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH Kombinationstherapeutikum
US12171880B2 (en) * 2022-09-08 2024-12-24 Taiwan Mercury Medical Corporation Metformin tablet for relieving pain and reducing inflammation and manufacturing method thereof
CN115607518B (zh) * 2022-09-16 2024-02-06 四川制药制剂有限公司 一种磷酸特地唑胺片及其制备方法
CN115429885B (zh) * 2022-10-26 2024-07-02 江苏集萃新型药物制剂技术研究所有限公司 治疗风湿的药物组合物、口服剂型及其制备方法
CN115517366B (zh) * 2022-11-02 2024-04-02 宝健(北京)生物技术有限公司 一种缩短崩解时限和减缓β-胡萝卜素衰减的螺旋藻片剂及其制备方法
WO2024108082A1 (en) 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Orodispersive dosage forms containing droxidopa
AU2022275454B2 (en) * 2022-11-23 2025-02-13 Taiwan Mercury Medical Corporation Metformin tablet for relieving pain and reducing inflammation and manufacturing method thereof
CN115919866A (zh) * 2022-12-07 2023-04-07 深圳海王医药科技研究院有限公司 特泊替尼固体分散体及其制备方法
CN116617159B (zh) * 2023-05-17 2025-07-25 时森海(杭州)医药科技有限公司 一种环硅酸锆钠口服混悬液及其制备方法
CN116650448A (zh) * 2023-06-27 2023-08-29 杭州成邦医药科技有限公司 一种莱博雷生口腔膜剂及其制备方法
CN117298057A (zh) * 2023-10-27 2023-12-29 重庆康刻尔制药股份有限公司 一种非奈利酮口崩片及其制备方法
US20250161207A1 (en) * 2023-11-20 2025-05-22 Altria Client Services Llc Oral products, three-dimensional printers used for forming oral products, and three-dimensional printing methods for forming oral products
AU2024227385A1 (en) * 2024-03-28 2025-10-16 Athena Pharmaceutiques Sas Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof
WO2025219830A1 (en) * 2024-04-15 2025-10-23 Novartis Ag Pharmaceutical compositions of ribociclib
CN119074887B (zh) * 2024-07-31 2025-01-28 中国医学科学院医药生物技术研究所 一种治疗肿瘤的综合靶向药物复合物及其制剂和用途
CN118766941B (zh) * 2024-08-14 2025-11-14 中国药科大学 洛美他派及其组合物在制备治疗肝纤维化的药物中的应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4631837A (en) 1985-05-31 1986-12-30 Magoon Richard E Method and apparatus for drying fruit pulp and the like
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
WO1995001782A2 (en) 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US6280771B1 (en) * 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US5738875A (en) 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
DE69840495D1 (de) 1997-02-20 2009-03-12 Massachusetts Inst Technology Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
US6047484A (en) 1998-07-10 2000-04-11 Bolland; Karin Marie Method and apparatus for evaporating liquid from a product
WO2001087272A2 (en) 2000-05-18 2001-11-22 Therics, Inc. Encapsulating a toxic core within a non-toxic region in an oral dosage form
WO2003037244A2 (en) 2001-10-29 2003-05-08 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
WO2003037632A1 (en) 2001-10-29 2003-05-08 Therics, Inc. A method and system for controlling the temperature of a dispensed liquid
CA2483028C (en) 2002-05-06 2011-04-05 Massachusetts Institute Of Technology Diffusion-controlled dosage form and method of fabrication including three dimensional printing
AU2004238321B2 (en) 2003-05-07 2009-08-27 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
FR2858556B1 (fr) 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US6990748B2 (en) 2003-09-12 2006-01-31 Karin M. Bolland Method and apparatus for evaporating liquid from a product
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
US20110014295A1 (en) 2007-02-23 2011-01-20 Glatt Air Techniques, Inc. Method of determining the weight of the coating to be applied to form a controlled release dosage form
US20090060983A1 (en) 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
ES2633449T3 (es) 2007-10-31 2017-09-21 Johnson & Johnson Consumer Inc. Forma de dosis oralmente desintegrable
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
DE102012011795A1 (de) 2012-06-15 2013-12-19 Harro Höfliger Verpackungsmaschinen GmbH Kapillardosierer und Verfahren zum Betrieb eines solchen Kapillardosierers
US8888480B2 (en) 2012-09-05 2014-11-18 Aprecia Pharmaceuticals Company Three-dimensional printing system and equipment assembly
US20140099351A1 (en) 2012-10-04 2014-04-10 Axxia Pharmaceuticals, Llc Process for making controlled release medical implant products
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
ES2761265T3 (es) 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación de oxcarbazepina rápidamente dispersable
WO2014144661A1 (en) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
DE102014004815A1 (de) 2013-04-03 2014-10-09 Glatt Ingenieurtechnik Gmbh Rotationstrocknerstern und Verfahren zur Behandlung von Feststoffpartikeln
DE202013004663U1 (de) 2013-05-17 2013-06-04 Harro Höfliger Verpackungsmaschinen GmbH Stechheber zum volumetrischen Dosieren von Pulver
EP3003964B1 (en) 2013-06-07 2021-04-14 Cavendish Kinetics, Inc. Non-symmetric arrays of mems digital variable capacitor with uniform operating characteristics
EP2902327B1 (de) 2014-02-01 2016-01-27 Harro Höfliger Verpackungsmaschinen GmbH Doseiereinrichtung für Pulver und Verfahren zur Dosierung von Pulver
US9844930B2 (en) 2014-11-05 2017-12-19 Xerox Corporation 3D printing of digestible shells for medicaments
CH710350A2 (de) 2014-11-10 2016-05-13 Chemspeed Tech Ag Dosiervorrichtung.
EP4512394A3 (en) 2015-06-03 2025-10-22 Triastek, Inc. Dosage forms and use thereof
CA2996041A1 (en) 2015-08-21 2017-03-02 Aprecia Pharmaceuticals LLC Three-dimensional printing system and equipment assembly
ITUA20163077A1 (it) 2016-05-02 2017-11-02 Mg 2 Srl Gruppo di alimentazione per il dosaggio di granuli, in particolare microgranuli, in capsule
EP3279618B1 (de) 2016-08-01 2021-02-24 Harro Höfliger Verpackungsmaschinen GmbH Kalibriereinrichtung und verfahren zur dosierung von darreichungseinheiten
BE1024613B1 (fr) 2016-09-29 2018-05-02 Aerosint Sa Dispositif et méthode pour créer une structure de particules
GB201620066D0 (en) 2016-11-28 2017-01-11 Ucl Business Plc Solid Pharmaceutical dosage formulations and processes
US10056912B1 (en) 2017-02-23 2018-08-21 Avago Technologies General Ip (Singapore) Pte. Ltd. Simultaneous cancellation of multiple spurs from different sources
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
BR112021001350A2 (pt) 2018-07-18 2021-04-20 Glatt Gmbh formulações de liberação imediata de canabinoides
ES2930199T3 (es) 2018-10-15 2022-12-07 Aprecia Pharmaceuticals LLC Método y sistema para formar una forma farmacéutica dentro de un envase

Also Published As

Publication number Publication date
CN116018131A (zh) 2023-04-25
US11433022B2 (en) 2022-09-06
AU2021296908A1 (en) 2023-02-16
US20230270665A1 (en) 2023-08-31
CA3183295A1 (en) 2021-12-30
JP2023533478A (ja) 2023-08-03
EP4171518A1 (en) 2023-05-03
US12485088B2 (en) 2025-12-02
US20220054409A1 (en) 2022-02-24
WO2021263132A1 (en) 2021-12-30
EP4171518C0 (en) 2024-12-11
EP4171518B1 (en) 2024-12-11

Similar Documents

Publication Publication Date Title
MX2022016117A (es) Tabletas rapidamente orodispersables que tienen una cavidad interior.
EP2645992B1 (en) Solid oral dosage form with asymmetric shape
AR084713A1 (es) Tapon lagrimal que contiene formulacion de farmaco
JP2005528383A5 (es)
WO2007075545A3 (en) Active drainage system for use in defined natural or surgically created body cavities or lumina
CN107072980A (zh) 在药物递送中使用的用于大麻素包衣的组合物和方法
CN109562184A (zh) 硬度改善的硬胶囊及其制造方法
DE502006001826D1 (de) Zweiteilige kapsel mit vorverschluss zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren
KR101870818B1 (ko) 한방용 환 및 그의 제조방법
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
MX2021004300A (es) Capsulas blandas con matriz de relleno polimerico solido o similar a un gel.
CN205470725U (zh) 泡腾片的包装结构
CN202875846U (zh) 一种胶囊的壳体结构
CN201768171U (zh) 用于盛装药液的分隔式药瓶
RU2010135467A (ru) Применение s-аденозилметионина (sam) и суперксиддисмутазы (sod) для изготовления лекарственных средств для лечения болезни альцгеймера
CN202620275U (zh) 六味补血胶囊
CN202314360U (zh) 注射用头孢拉宗钠双室输液包装
CN205150719U (zh) 一种干混悬剂、颗粒剂药物的分剂量工具
CN109044840A (zh) 一种包含软胶囊的硬胶囊
CN222399562U (zh) 一种保护益生菌的冷压片剂结构
CN201214497Y (zh) 一种封闭式药匙
CN210750324U (zh) 一种用药提醒器
CN210520291U (zh) 一种抽屉式便携药盒
CN211253416U (zh) 一种粉液分离的液态面膜包装
CN102793686A (zh) 空胶囊的制备方法